Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Chlamydia and Gonorrhea Treatment Guidelines

Introduction to Treatment Options

  • The American College of Physicians recommends azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days for uncomplicated chlamydial infections, with efficacy rates of 97% and 98% respectively 1, 2
  • The Centers for Disease Control and Prevention recommends ceftriaxone 500 mg intramuscularly as a single dose for uncomplicated gonorrhea at all anatomic sites, although this specific recommendation is not directly cited here, alternative sources suggest this as a standard treatment

Chlamydia Treatment Considerations

  • For alternative chlamydia treatments, erythromycin base 500 mg orally four times a day for 7 days, erythromycin ethylsuccinate 800 mg orally four times a day for 7 days, levofloxacin 500 mg orally once daily for 7 days, and ofloxacin 300 mg orally twice a day for 7 days are options, as per MMWR Recommendations and Reports 3, 2
  • Azithromycin has advantages including single-dose therapy and better compliance, while doxycycline has a lower cost and extensive clinical experience 1, 2
  • Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance, as suggested by MMWR Recommendations and Reports and Praxis Medical Insights 3, 2

Gonorrhea and Dual Therapy

  • Patients with gonorrhea often have co-infection with chlamydia, at rates of 20-40%, and when treating gonorrhea, if chlamydial infection has not been excluded, treatment for both infections should be provided, according to MMWR Recommendations and Reports 4
  • Routine dual therapy without testing for chlamydia can be cost-effective when co-infection rates are high, as noted by MMWR Recommendations and Reports 4

Implementation and Special Populations

  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, and from sexual activity until all sex partners are treated, as recommended by MMWR Recommendations and Reports and Praxis Medical Insights 3, 2
  • All sex partners from the previous 60 days should be evaluated, tested, and treated, according to Praxis Medical Insights 2
  • For chlamydia during pregnancy, recommended treatments are azithromycin 1 g orally in a single dose and amoxicillin 500 mg orally three times a day for 7 days, while doxycycline and fluoroquinolones are contraindicated, as per Praxis Medical Insights 1
  • Test-of-cure is not routinely recommended after completing treatment with recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected, as suggested by Praxis Medical Insights and MMWR Recommendations and Reports 2, 3

Common Considerations

  • Gastrointestinal side effects with erythromycin often lead to poor compliance, making it a less desirable alternative, as noted by Praxis Medical Insights 2
  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection, according to Praxis Medical Insights 2

REFERENCES

1

Chlamydia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Chlamydia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025